AFT Pharmaceuticals - Latest News [Page 2]

Kiwi company secures funding for international growth

Monday, 19 May 2014, 1:15 pm | AFT Pharmaceuticals

Auckland pharmaceutical company, AFT Pharmaceuticals, has secured major capital investment from United States and New Zealand investors that will allow the company to make further inroads into the global pharmaceutical market. More >>

Views of NZ self-medication body at odds with safety

Tuesday, 25 March 2014, 1:32 pm | AFT Pharmaceuticals

AFT Pharmaceuticals (AFT) has identified a major error with the formulation of over 1300 cold and flu products used around the world. Many over-the-counter (OTC) cold and flu products combine phenylephrine and paracetamol. More >>

NZ company finds major error with cold and flu products

Thursday, 20 March 2014, 11:27 am | AFT Pharmaceuticals

New Zealand company finds major formulation error with cold and flu products worth NZ$1.4 billion worldwide More >>

Codeine A Conundrum For Kiwi Consumers

Sunday, 1 August 2010, 11:51 am | AFT Pharmaceuticals

A survey has found about a quarter (24 per cent) of New Zealanders who used an over-the-counter painkiller in the past three months took one which contained codeine – and half of those people (47 per cent) consumed the addictive drug unwittingly. More >>

Kiwi Co. pops pill into US$20b pain-relief market

Wednesday, 28 October 2009, 10:16 am | AFT Pharmaceuticals

New Zealanders will find a home-grown answer to pain relief on the shelves at their local pharmacy this month with the launch of a new drug that represents a world breakthrough. New Zealand-owned AFT Pharmaceuticals has commercialised a new pain relief tablet, ... More >>

NZ drug company challenges industry to go P-free

Wednesday, 27 May 2009, 4:22 pm | AFT Pharmaceuticals

New Zealand pharmaceutical manufacturer AFT Pharmaceuticals is backing the Prime Minister’s bid to ban pseudoephedrine from cold and flu tablets. As pharmacists debate whether cold and flu pills containing pseudoephedrine should be removed from ... More >>

NZ’s AFT targets $15 billion pain relief market

Friday, 26 September 2008, 10:53 am | AFT Pharmaceuticals

AFT Pharmaceuticals, a 100 per cent New Zealand owned company, has researched and developed a novel therapy which represents a breakthrough in pain relief. Progress for the international launch of the unique pain relief (analgesic) product (combining ... More >>